INTERNATIONAL PATENT: GILEAD SCIENCES, INC. FILES APPLICATION FOR "USE OF TPL2 INHIBITORS, SUCH AS A PRODRUG OF TILPISERTIB, TO TREAT INFLAMMATORY BOWEL DISEASE OR ULCERATIVE COLITIS"

GENEVA, June 25 -- GILEAD SCIENCES, INC. (333 Lakeside DriveFoster City, California 94404) filed a patent application (PCT/US2024/059225) for "USE OF TPL2 INHIBITORS, SUCH AS A PRODRUG OF TILPISERTIB, TO TREAT INFLAMMATORY BOWEL DISEASE OR ULCERATIVE COLITIS" on Dec 09, 2024. With publication no. WO/2025/128492, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEBER, Elijah J. (1106 Shrader StreetSan Francisco, California 94117), OTHMAN, Ahmed A. (2281 Forino DriveDublin, California 94568), CHANG, Ingrid J. (1858 S. Washin...